Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis

NCT07756268 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: SYS6020 injection

Sponsor

Tongji Hospital

Collaborators

[object Object]